首页> 外文期刊>Pharmaceutical Chemistry Journal >HYDROPHILIC HEXAPEPTIDES: A NEW CLASS OF REGULATORS OF ATP-DEPENDENT TRANSPORT PROTEINS OF MULTIPLE DRUG RESISTANCE
【24h】

HYDROPHILIC HEXAPEPTIDES: A NEW CLASS OF REGULATORS OF ATP-DEPENDENT TRANSPORT PROTEINS OF MULTIPLE DRUG RESISTANCE

机译:亲水性六肽:一类多药抗ATP依赖性运输蛋白的调节剂

获取原文
获取原文并翻译 | 示例
       

摘要

Multiple drug resistance (MDR) appears as a result of sharply increased elimination of drugs from a cell into the extracellular space by ATP-dependent transport proteins. At present, no effective inhibitor of transport proteins is available that could be used to overcome MDR. The influence of two hydrophilic hexapeptides, imunofan and biopoetin, on the activity and amount of transport proteins responsible for MDR formation has been investigated using cell lines of human throat cancer (Hep-2), human oral cavity carcinoma (KB8-5), and human prostate cancer (PC-3). The effect of the hexapeptides was evaluated by comparing the Rh 123 expulsion rate and the expression of transport proteins and their genes. It is established that the indicated hydrophilic hexapeptides in very low concentrations (of the order of 10"10 M) inhibit the substrate expulsion from a cell into the extracellular space. However, the two hydrophilic hexapeptides modulate MDR by different mechanisms. Imunofan and biopoetin are the first tumor MDR inhibitors showing activity at such low concentrations.
机译:多重耐药性(MDR)的出现是由于依赖ATP的转运蛋白将药物从细胞清除到细胞外空间的急剧增加的结果。目前,没有有效的转运蛋白抑制剂可用于克服MDR。已使用人喉癌(Hep-2),人口腔癌(KB8-5)和人喉癌细胞系研究了两种亲水性六肽Imofofan和biopoetin对负责MDR形成的转运蛋白活性和数量的影响。人类前列腺癌(PC-3)。通过比较Rh 123的排出速率和转运蛋白及其基因的表达来评估六肽的作用。已经确定,所示的亲水性六肽浓度非常低(约10“ 10 M),可抑制底物从细胞向细胞外空间的排出。但是,这两种亲水性六肽通过不同的机制调节MDR。第一批肿瘤MDR抑制剂在如此低的浓度下表现出活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号